KD Logo

An Analysis of Aligos Therapeutics Inc (ALGS)’s Potential Price Growth

ZOM Stock

Aligos Therapeutics Inc’s filing revealed that its Director Nuechterlein Carole acquired Company’s shares for reported $6.0 million on Oct 25 ’23. In the deal valued at $0.76 per share,7,933,601 shares were bought. As a result of this transaction, Nuechterlein Carole now holds 11,025,941 shares worth roughly $9.15 million.

Piper Sandler upgraded its Aligos Therapeutics Inc [ALGS] rating to an Overweight from a a Neutral in a research note published on January 06, 2023; the price target was increased to $3 from $2. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early January from “a Hold” to “a Buy”. Piper Sandler also remained covering ALGS and has decreased its forecast on March 23, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. JP Morgan revised its rating on January 07, 2022. It rated ALGS as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of ALGS

On Tuesday, Aligos Therapeutics Inc [NASDAQ:ALGS] saw its stock fall -6.67% to $0.83. Over the last five days, the stock has lost -21.23%. Aligos Therapeutics Inc shares have risen nearly 25.75% since the year began. Nevertheless, the stocks have fallen -10.21% over the past one year. While a 52-week high of $1.38 was reached on 03/04/24, a 52-week low of $0.54 was recorded on 02/15/24. SMA at 50 days reached $0.8844, while 200 days put it at $0.8031. A total of 0.25 million shares were traded, compared to the trading of 0.33 million shares in the previous session.

Levels Of Support And Resistance For ALGS Stock

The 24-hour chart illustrates a support level at 0.7867, which if violated will result in even more drops to 0.7383. On the upside, there is a resistance level at 0.8967. A further resistance level may holdings at 0.9583. The Relative Strength Index (RSI) on the 14-day chart is 38.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0809, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.33%. Stochastics %K at 23.94% indicates the stock is a holding.

Most Popular

[the_ad id="945"]